150 related articles for article (PubMed ID: 9709951)
1. Outcome of differentiated thyroid cancer in Graves' patients.
Pellegriti G; Belfiore A; Giuffrida D; Lupo L; Vigneri R
J Clin Endocrinol Metab; 1998 Aug; 83(8):2805-9. PubMed ID: 9709951
[TBL] [Abstract][Full Text] [Related]
2. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
[TBL] [Abstract][Full Text] [Related]
3. Recent outcome of Graves' disease patients with papillary thyroid cancer.
Yano Y; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K; Ito K
Eur J Endocrinol; 2007 Sep; 157(3):325-9. PubMed ID: 17766715
[TBL] [Abstract][Full Text] [Related]
4. Increased aggressiveness of thyroid cancer in patients with Graves' disease.
Belfiore A; Garofalo MR; Giuffrida D; Runello F; Filetti S; Fiumara A; Ippolito O; Vigneri R
J Clin Endocrinol Metab; 1990 Apr; 70(4):830-5. PubMed ID: 2180978
[TBL] [Abstract][Full Text] [Related]
5. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.
Pellegriti G; Mannarino C; Russo M; Terranova R; Marturano I; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 2013 Mar; 98(3):1014-21. PubMed ID: 23348395
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
7. Graves' disease and thyroid cancer.
Behar R; Arganini M; Wu TC; McCormick M; Straus FH; DeGroot LJ; Kaplan EL
Surgery; 1986 Dec; 100(6):1121-7. PubMed ID: 3787468
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease?
Tamatea JA; Tu'akoi K; Conaglen JV; Elston MS; Meyer-Rochow GY
ANZ J Surg; 2014 Apr; 84(4):231-4. PubMed ID: 22985335
[TBL] [Abstract][Full Text] [Related]
9. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
10. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
[TBL] [Abstract][Full Text] [Related]
11. Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
Premoli P; Tanda ML; Piantanida E; Veronesi G; Gallo D; Masiello E; Rosetti S; Cusini C; Boi F; Bulla J; Rodia R; Mariotti S; Capelli V; Rotondi M; Magri F; Chiovato L; Rocchi R; Campopiano MC; Elisei R; Vitti P; Barbato F; Pilli T; Castagna MG; Pacini F; Bartalena L
J Endocrinol Invest; 2020 Jan; 43(1):109-116. PubMed ID: 31327128
[TBL] [Abstract][Full Text] [Related]
12. Thyroid cancer yield in patients with Graves' disease.
Stocker DJ; Burch HB
Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
[TBL] [Abstract][Full Text] [Related]
13. Thyroid carcinoma in Graves' disease.
Farbota LM; Calandra DB; Lawrence AM; Paloyan E
Surgery; 1985 Dec; 98(6):1148-53. PubMed ID: 2866590
[TBL] [Abstract][Full Text] [Related]
14. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of small thyroid cancer in patients with Graves' disease.
Kikuchi S; Noguchi S; Yamashita H; Uchino S; Kawamoto H
Br J Surg; 2006 Apr; 93(4):434-9. PubMed ID: 16523447
[TBL] [Abstract][Full Text] [Related]
16. Thyroid nodules in Graves' disease: implications in an endemically iodine deficient area.
Mishra A; Mishra SK
J Postgrad Med; 2001; 47(4):244-7. PubMed ID: 11832639
[TBL] [Abstract][Full Text] [Related]
17. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
Li J; Gao H; Jin SX
Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
